A critical role of trail expressed on cotransplanted hepatic stellate cells in prevention of islet allograft rejection

Microsurgery

Volumn 30, Issue 4, 2010, Pages 332-337

  Yang, Horng Ren ^a,b   Hsieh, Ching Chuan ^a   Wang, Lianfu ^a   Fung, John J ^a   Lu, Lina ^a   Qian, Shiguang ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOREGULATION; MALE; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STELLATE CELL; STREPTOZOCIN DIABETES; T LYMPHOCYTE;

ANIMALS; BIOLOGICAL MARKERS; CELL PROLIFERATION; CELL TRANSPLANTATION; DENDRITIC CELLS; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; HEPATIC STELLATE CELLS; ISLETS OF LANGERHANS TRANSPLANTATION; KAPLAN-MEIERS ESTIMATE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RANDOM ALLOCATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSPLANTATION, HOMOLOGOUS;

EID: 77953006325     PISSN: 07381085     EISSN: 10982752     Source Type: Journal    
DOI: 10.1002/micr.20697     Document Type: Article

References (28)

1. Qian S, Fung JJ, Demetris AJ, Ildstad S, Starzl TE. Orthotopic liver transplantation in mice. Transplantation 1991;52:562-564.
2. Qian S, Demetris AJ, Murase N, Rao AS, Fung JJ, Starzl TE. Murine liver allograft transplantation: Tolerance and donor cell chimerism. Hepatology 1994;19:916-924. (Pubitemid 24109354)
3. Dahmen U, Qian S, Rao AS, Demetris AJ, Fu F, Sun H, Gao L, Fung JJ, Starzl TE. Split tolerance induced by orthotopic liver transplantation in mice. Transplantation 1994;58:1-8. (Pubitemid 24224475)
4. Qian S, Lu L, Li Y, Fu F, Li W, Starzl TE, Fung JJ, Thomson AW. Apoptosis within spontaneously accepted mouse liver allografts: Evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol 1997;158:4654-4661. (Pubitemid 127483783)
5. + regulatory T cells. Am J Transplant 2008;8:1639-1651.
6. Ilan Y, Sauter B, Chowdhury NR, Reddy BV, Thummala NR, Droguett G, Davidson A, Ott M, Horwitz MS, Chowdhury JR. Oral tolerization to adenoviral proteins permits repeated adenovirus-mediated gene therapy in rats with pre-existing immunity to adenoviruses. Hepatology 1998;27:1368-1376. (Pubitemid 28227866)
7. Callery MP, Kamei T, Flye MW. The effect of portacaval shunt on delayed hypersensitivity responses following antigen feeding. J Surg Res 1989;46:391-394. (Pubitemid 19124274)
8. Yu S, Nakafusa Y, Flye MW. Portal vein administration of donor cells promotes peripheral allospecific hyporesponsiveness and graft tolerance. Surgery 1994;116:229-235. (Pubitemid 24260712)
9. Bumgardner GL, Li J, Heininger M, Ferguson RM, Orosz CG. In vivo immunogenicity of purified allogeneic hepatocytes in a murine hepatocyte transplant model. Transplantation 1998;65:47-52.
10. Bumgardner GL, Neininger M, Li J, Xia D, Parker-Thornburg J, Frguson RM, Orosz CG. A functional model of hepatocyte transplantation for in vivo immunologic studies. Transplantation 1998;65:53-61. (Pubitemid 28100431)
11. Yu MC, Chen CH, Liang X, Wang L, Gandhi CR, Fung JJ, Lu L, Qian S. Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice. Hepatology 2004;40: 1312-1321. (Pubitemid 39657005)
12. Chen CH, Kuo LM, Chang Y, Wu W, Goldbach C, Ross MA, Stolz DB, Chen L, Fung JJ, Lu L, Qian S. In vivo immune modulatory activity of hepatic stellate cells in mice. Hepatology 2006;44:1171-1181.
13. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA, Goodwin RG. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995;3:673-682. (Pubitemid 26091143)
14. Wang SH, Mezosi E, Wolf JM, Cao Z, Utsugi S, Gauger PG, Doherty GM, Baker JR Jr. IFN-gamma sensitization to TRAIL-induced apoptosis in human thyroid carcinoma cells by upregulating Bak expression. Oncogene 2004;23:928-935. (Pubitemid 38250938)
15. Kagawa S, He C, Gu J, Koch P, Rha SJ, Roth JA, Curley SA, Stephens LC, Fang B. Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene. Cancer Res 2001;61:3330-3338. (Pubitemid 32695022)
16. + T-cell death induced by infectious and noninfectious HIV-1: Role of type1 interferon-dependent, TRAIL/DR5-mediated apoptosis Blood 2005;106:3524-3531.
17. Ursini-Siegel J, Zhang W, Altmeyer A, Hatada EN, Do RK, Yagita H, Chen-Kiang S. TRAIL/Apo-2 ligand induces primary plasma cell apoptosis. J Immunol 2002;169:5505-5513. (Pubitemid 35291648)
18. Phillips TA, Ni J, Pan G, Ruben SM, Wei YF. Pace JL, Hunt JS. TRAIL (Apo-2L) and TRAIL receptors in human placentas: implications for immune privilege. J Immunol 1999;162:6053-6059. (Pubitemid 29314964)
19. Song K, Chen Y, Goke R, Wilmen A, Seidel C, Goke A, Hilliard B, Chen Y. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression. J Exp Med 2000;191:1095-1104. (Pubitemid 30207673)
20. Hilliard B, Wilmen A, Seidel C, Liu TS, Goke R, Chen Y. Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis. J Immunol 2001;166:1314-1319. (Pubitemid 32060293)
21. Mi QS, Ly D, Lamhamedi-Cherradi SE, Salojin KV, Zhou L, Grattan M, Meagher C, Zucker P, Chen YH, Nagle J, Taub D, Delovitch TL. Blockade of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Exacerbates Type 1 Diabetes in NOD Mice. Diabetes 2003; 52:1967-1975. (Pubitemid 36919788)
22. Wang SH, Cao Z, Wolf JM, Van Antwerp M, Baker JR Jr. Death ligand tumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis. Endocrinology 2005;146: 4721-4726. (Pubitemid 41446609)
23. Liu Z, Xu X. Hsu HC, Tousson A, Yang PA, Wu Q, Liu C, Yu S, Zhang HG, Mountz JD. CII-DC-Ad TRAIL cell gene therapy inhibits infiltration of CII-reactive T cells and CII-induced arthritis. J Clin Invest 2003;112:1332-1341. (Pubitemid 38057687)
24. Corazza N, Brumatti G, Schaer C, Cima I, Wasem C, Brunner T. TRAIL and immunity: More than a license to kill tumor cells. Cell Death Differ 2004;11:S122-S125.
25. Guo Y, Chen C, Zheng Y, Zhang J, Tao X, Liu S, Zheng D, Liu Y. A novel anti-human DR5 monoclonal antibody with tumoricidal activity induces caspase-dependent and caspase-independent cell death. J Biol Chem 2005;280:41940-41952. (Pubitemid 43023163)
26. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC, Lynch DH. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 1999;5:157-163. (Pubitemid 29068521)
27. Schneider P, Bodmer JL, Thome M, Hofmann K, Holler N, Tschopp J. Characterization of two receptors for TRAIL. FEBS Lett 1997; 416:329-334.
28. Mariani SM, Krammer PH. Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells. Eur J Immunol 1998;28: 1492-1498. (Pubitemid 28221151)